Ignite Creation Date:
2025-12-24 @ 9:10 PM
Ignite Modification Date:
2025-12-29 @ 5:53 AM
Study NCT ID:
NCT03961204
Status:
COMPLETED
Last Update Posted:
2023-10-31
First Post:
2019-05-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Long-Term Outcomes and Durability of Effect Following Treatment With Cladribine Tablets for MS (CLASSIC-MS)
Sponsor:
EMD Serono Research & Development Institute, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-08-15
Start Date Type:
ACTUAL
Primary Completion Date:
2021-02-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-05-13
Completion Date Type:
ACTUAL
First Submit Date:
2019-05-22
First Submit QC Date:
None
Study First Post Date:
2019-05-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-02-22
Results First Submit QC Date:
None
Results First Post Date:
2022-05-05
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-10-26
Last Update Post Date:
2023-10-31
Last Update Post Date Type:
ACTUAL